Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Trial Number
NCT00565851 (ClinicalTrials.gov Identifier)Contact Person
Status
Recruiting
Disease Site
Recurrent Ovarian